CLOs on the Move

NCH Healthcare System

www.nchmd.org

 
The NCH Healthcare System is a not-for-profit multi-facility healthcare system located in Naples, Florida. The system includes two hospitals (NCH Healthcare System – Downtown Naples Hospital and NCH Healthcare System – North Naples Hospital) with a total of 681 beds collaborating with 630 physicians to care for more than 32,000 patients each year. Outpatient facilities include Walk-in Centers, Wellness Centers, Rehabilitation Centers, Wound Care Facilities, and Infusion Centers in Naples, North Naples, Marco Island, Bonita Springs, and Estero. NCH`s Emergency Departments and outpatient facilities had over 120,000 visits for the past two years. Caring for all ages in the communities it serves, NCH ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million
  • www.nchmd.org
  • 350 7th Street North
    Naples, FL USA 34102
  • Phone: 239.624.5000

Executives

Name Title Contact Details

Similar Companies

GCG Healthcare Group

GCG Healthcare Group is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

That Touch Of Class

That Touch Of Class is a Caro, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sadra Medical

Sadra Medical is a Los Gatos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nivalis Therapeutics

Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.

Destination Pet

Welcome to your destination. Our mission is simple: to provide the best for your pet.